Effect of pharmacological wash-out in patients undergoing exercise testing after acute myocardial infarction

被引:6
作者
Bigi, R
Verzoni, A
Cortigiani, L
De Chiara, B
Desideri, A
Fiorentini, C
机构
[1] CNR, Inst Clin Physiol, Milan, Italy
[2] S Paolo Acad Hosp, Div Cardiol, Milan, Italy
[3] Campo Marte Hosp, Cardiovasc Unit, Lucca, Italy
[4] Cardiovasc Res Fdn, Castelfranco Veneto, Italy
关键词
acute myocardial infarction; prognostic stratification; exercise stress testing; ECG Holter monitoring; pharmacological therapy;
D O I
10.1016/j.ijcard.2003.12.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Study objectives: Pharmacological therapy can reduce diagnostic and prognostic accuracy of exercise stress testing. However, the risk of withdrawing drugs early after myocardial infarction (MI) has not been established. We assessed safety and clinical implications of drug withdrawal in patients undergoing stress testing after uncomplicated MI. Methods: A total of 362 MI patients underwent ECG Holier recording before and after withdrawing beta-blockers, calcium-antagonists and nitrates. QRS (QRS/h) and ventricular premature beats (VPB/h) count per hour, repetitive ventricular arrhythmias, ST segment changes and patient complaints were evaluated for reproducibility using kappa statistics and Bland-Altman method. Results: No major complications occurred. Forty-three patients complained of > 1 symptom on and 37 off therapy. QRS/h and VPB/h count were significantly (p < 0.0001) higher off therapy but correlated with the corresponding values on therapy. A mean heart rate increase of 8 beats/min (agreement range -8 to +14 beats/min) and a five-fold increase in VPB/h (agree rent range -141 to +151) were observed after withdrawing therapy. Repetitive ventricular arrhythmias and ST changes were also more frequent off therapy but intra-patient reproducibility was poor: kappa 0.12 (95% confidence interval (CI) -0.01 to 0.25) for arrhythmias, -0.02 (95% CI -0.46 to 0.39) for ST depression and -0.01 (95% CI -0.66 to 0.64) for ST elevation. Conclusions: The withdrawal of therapy is well tolerated soon after uncomplicated MI; however, a generic but not individual risk of ventricular arrhythmias and/or transient myocardial ischemia has to be taken into account. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:277 / 281
页数:5
相关论文
共 17 条
[1]   EFFECT OF METOPROLOL ON THE SUBMAXIMAL STRESS TEST PERFORMED EARLY AFTER ACUTE MYOCARDIAL-INFARCTION [J].
ADES, PA ;
THOMAS, JD ;
HANSON, JS ;
SHAPIRO, SM ;
LAMOUNTAIN, J .
AMERICAN JOURNAL OF CARDIOLOGY, 1987, 60 (13) :963-966
[2]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[3]   IMPACT OF TREATMENT STRATEGY ON PREDISCHARGE EXERCISE TEST IN THE THROMBOLYSIS IN MYOCARDIAL-INFARCTION (TIMI) II-TRIAL [J].
CHAITMAN, BR ;
MCMAHON, RP ;
TERRIN, M ;
YOUNIS, LT ;
SHAW, LJ ;
WEINER, DA ;
FREDERICK, MM ;
KNATTERUD, GL ;
SOPKO, G ;
BRAUNWALD, E .
AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (02) :131-138
[4]   PROPRANOLOL THERAPY ALTERS ESTIMATION OF POTENTIAL CARDIOVASCULAR RISK DERIVED FROM SUBMAXIMAL POSTINFARCTION EXERCISE TESTING [J].
CURTIS, JL ;
HOUGHTON, JL ;
PATTERSON, JH ;
KOCH, G ;
BRADLEY, DA ;
ADAMS, KF .
AMERICAN HEART JOURNAL, 1991, 121 (06) :1655-1664
[5]  
Gibbons RJ, 1997, J AM COLL CARDIOL, V30, P260
[6]   PREDICTION OF CORONARY EVENTS FOLLOWING MYOCARDIAL-INFARCTION USING A DISCRIMINANT FUNCTION-ANALYSIS [J].
HSU, L ;
SENARATNE, MPJ ;
DESILVA, S ;
ROSSALL, RE ;
KAPPAGODA, T .
JOURNAL OF CHRONIC DISEASES, 1986, 39 (07) :543-552
[7]   COMPARISON OF SYMPTOM-LIMITED AND LOW-LEVEL EXERCISE TOLERANCE-TESTS EARLY AFTER MYOCARDIAL-INFARCTION [J].
JAIN, A ;
MYERS, GH ;
SAPIN, PM ;
OROURKE, RA .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1993, 22 (07) :1816-1820
[8]   SYMPTOM-LIMITED VERSUS LOW-LEVEL EXERCISE TESTING BEFORE HOSPITAL DISCHARGE AFTER MYOCARDIAL-INFARCTION [J].
JUNEAU, M ;
COLLES, P ;
THEROUX, P ;
DEGUISE, P ;
PELLETIER, G ;
LAM, J ;
WATERS, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (04) :927-933
[9]   SHOULD ANTIANGINAL MEDICATION BE STOPPED FOR EXERCISE TESTING [J].
LIM, R ;
DYMOND, DS .
LANCET, 1992, 340 (8812) :161-162
[10]  
MURRAY DP, 1988, BRIT HEART J, V60, P474